Advair Diskus

We previously demonstrated pharmacokinetic differences among manufacturing batches of a US Food and Drug Administration (FDA… Expand

Rationale: OT329 SOLIS is a generic candidate for the branded asthma treatment, ADVAIR DISKUS (fluticasone propionate/salmeterol… Expand

The FDA has issued a requirement for manufacturers of long-acting beta-agonists (LABAs) marketed for asthma to conduct controlled… Expand

BACKGROUND This report presents results of the first human study of a new dry powder inhaler (DPI-C). DPI-C uses reverse flow… Expand

The LABAs have played an important role in the management of asthma over the past decade. They are of clear benefit in reducing… Expand

Context Although many Americans use the Internet to purchase drugs from Canadian pharmacies, no study has systematically… Expand

BACKGROUND Adherence to inhaled steroid regimens is frequently poor. Finding ways to improve adherence depends on the ability to… Expand

 

BACKGROUND Options for step-down therapy include use of inhaled corticosteroids alone or in combination with a long-acting beta2… Expand

Several classes of medications are available for the treatment of asthma, and often they must be taken concurrently to achieve… Expand